Glenn Gregory M

Average Profitability
76.53%
Insider Buys Quantity
23
Insider Buys Sum
$390,174.14
Insider Sells Quantity
43
Insider Sells Sum
$59.01M

Insider Activity of Glenn Gregory M

The largest purchase of all time was on 2018-05-14 and amounted to 40000 shares of Novavax, Inc. for $65,599.

The largest sale of all time was on 2020-08-18 and amounted to 111842 shares of Novavax, Inc. for $16.24M.

Biography of Glenn Gregory M

No biography is available at this moment.

2023-03-10PurchaseNovavax, Inc.
NVAX
President, R&D
1,000
0.0012%
$6.50$6,500+9.05%
2023-03-07PurchaseNovavax, Inc.
NVAX
President, R&D
2,000
0.0023%
$7.04$14,088+1.72%
2023-03-06PurchaseNovavax, Inc.
NVAX
President, R&D
3,000
0.0036%
$7.48$22,454-2.74%
2021-12-15SaleNovavax, Inc.
NVAX
President, R&D
1,686
0.0022%
$174.13$293,584-71.05%
2021-12-07SaleNovavax, Inc.
NVAX
President, R&D
8,250
0.0101%
$170.14$1.4M-70.62%
2021-11-30SaleNovavax, Inc.
NVAX
President, R&D
8,942
0.0115%
$203.20$1.82M-73.89%
2021-11-26SaleNovavax, Inc.
NVAX
President, R&D
2,083
0.0028%
$218.07$454,247-74.84%
2021-11-23SaleNovavax, Inc.
NVAX
President, R&D
8,250
0.0108%
$199.50$1.65M-72.49%
2021-11-16SaleNovavax, Inc.
NVAX
President, R&D
8,250
0.0108%
$169.48$1.4M-66.87%
2021-11-15SaleNovavax, Inc.
NVAX
President, R&D
1,183
0.0016%
$172.02$203,496-67.05%
2021-11-09SaleNovavax, Inc.
NVAX
President, R&D
8,250
0.0108%
$167.53$1.38M-66.11%
2021-11-02SaleNovavax, Inc.
NVAX
President, R&D
8,250
0.0103%
$183.82$1.52M-70.05%
2021-10-29SaleNovavax, Inc.
NVAX
President, R&D
680
0.0009%
$148.34$100,871-60.43%
2021-10-26SaleNovavax, Inc.
NVAX
President, R&D
10,334
0.0134%
$132.73$1.37M-55.9%
2021-10-19SaleNovavax, Inc.
NVAX
President, R&D
8,250
0.0112%
$165.14$1.36M-61.35%
2021-10-15SaleNovavax, Inc.
NVAX
President, R&D
1,183
0.0016%
$170.00$201,110-61.27%
2021-10-12SaleNovavax, Inc.
NVAX
President, R&D
8,250
0.0109%
$163.18$1.35M-60.32%
2021-10-05SaleNovavax, Inc.
NVAX
President, R&D
8,250
0.0112%
$174.41$1.44M-58.33%
2021-09-30SaleNovavax, Inc.
NVAX
President, R&D
693
0.0009%
$207.25$143,622-64.86%
2021-09-27SaleNovavax, Inc.
NVAX
President, R&D
2,083
0.0028%
$234.43$488,315-68.27%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.